Comera Life Sciences Reports Financial Results for Third Quarter 2023 and Recent Business Highlights

– Final stage of technical evaluation near completion in Comera’s research collaboration with Regeneron, a leading U.S. biotechnology company –

– Expanded and strengthened Comera’s global patent portfolio, broadening both geographic coverage and claims for core SQore excipient technology –